Literature DB >> 20625916

Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course.

Ilya Kister1, A B Caminero, T S Monteith, A Soliman, T E Bacon, J H Bacon, J T Kalina, M Inglese, J Herbert, R B Lipton.   

Abstract

The objectives of this study were: (1) to assess relative frequency of migraine in multiple sclerosis (MS) patients using the validated self-administered diagnostic questionnaire, and to compare the migraine rates in MS outpatients to age- and gender-matched historical population controls; (2) to compare clinical and radiographic characteristics in MS patients with migraine and headache-free MS patients. We conducted a cross-sectional study to assess the demographic profiles, headache features and clinical characteristics of MS patients attending a MS clinic using a questionnaire based on the American Migraine Prevalence and Prevention (AMPP) study. We compared the relative frequency of migraine in MS clinic patients and AMPP cohort. We also compared clinical and radiographic features in MS patients with migraine to an MS control group without headache. Among 204 MS patients, the relative frequency of migraine was threefold higher than in population controls both for women [55.7 vs. 17.1%; prevalence ratio (PR) =3.26, p<0.001] and men (18.4 vs. 5.6%; PR=3.29, p<0.001). In a series of logistic regression models that controlled for age, gender, disease duration, β-interferon use, and depression, migraine in MS patients was significantly associated (p<0.01) with trigeminal and occipital neuralgia, facial pain, Lhermitte's sign, temporomandibular joint pain, non-headache pain and a past history of depression. Migraine status was not significantly associated with disability on patient-derived disability steps scale or T2 lesion burden on brain MRI. Migraine is three-times more common in MS clinic patients than in general population. MS-migraine group was more symptomatic than the MS-no headache group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20625916      PMCID: PMC3452278          DOI: 10.1007/s10194-010-0237-9

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  29 in total

Review 1.  Headaches and multiple sclerosis: a clinical study and review of the literature.

Authors:  L A Rolak; S Brown
Journal:  J Neurol       Date:  1990-08       Impact factor: 4.849

2.  SPREADING DEPRESSION AND RECOVERY FROM LATERAL HYPOTHALAMIC DAMAGE.

Authors:  P TEITELBAUM; J CYTAWA
Journal:  Science       Date:  1965-01-01       Impact factor: 47.728

3.  Some aspects of the natural history of disseminated sclerosis.

Authors:  D McALPINE; N COMPSTON
Journal:  Q J Med       Date:  1952-04

4.  Migraine and psychopathology. Results of the Zurich cohort study of young adults.

Authors:  K R Merikangas; J Angst; H Isler
Journal:  Arch Gen Psychiatry       Date:  1990-09

5.  The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis.

Authors:  Joey R Gee; Joyce Chang; Arthur B Dublin; Nazhiyath Vijayan
Journal:  Headache       Date:  2005-06       Impact factor: 5.887

6.  An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score.

Authors:  W F Stewart; R B Lipton; J Whyte; A Dowson; K Kolodner; J N Liberman; J Sawyer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

7.  Prevalence of primary headaches in people with multiple sclerosis.

Authors:  D D'Amico; L La Mantia; A Rigamonti; S Usai; N Mascoli; C Milanese; G Bussone
Journal:  Cephalalgia       Date:  2004-11       Impact factor: 6.292

8.  Pain thresholds in daily transformed migraine versus episodic migraine headache patients.

Authors:  Madeleine B Kitaj; Michelle Klink
Journal:  Headache       Date:  2005-09       Impact factor: 5.887

9.  Disease steps in multiple sclerosis: a simple approach to evaluate disease progression.

Authors:  M J Hohol; E J Orav; H L Weiner
Journal:  Neurology       Date:  1995-02       Impact factor: 9.910

10.  Clinical recognition of allodynia in migraine.

Authors:  Ninan T Mathew; Jayasree Kailasam; Tad Seifert
Journal:  Neurology       Date:  2004-09-14       Impact factor: 9.910

View more
  28 in total

1.  Determinants of the severity of comorbid migraine in multiple sclerosis.

Authors:  Veronica Villani; Laura De Giglio; Giuliano Sette; Carlo Pozzilli; Marco Salvetti; Luca Prosperini
Journal:  Neurol Sci       Date:  2012-05-27       Impact factor: 3.307

2.  Headache in the course of multiple sclerosis: a prospective study.

Authors:  Marcel Gebhardt; Peter Kropp; Frank Hoffmann; Uwe K Zettl
Journal:  J Neural Transm (Vienna)       Date:  2018-11-30       Impact factor: 3.575

3.  Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II.

Authors:  Ilya Kister; Kassandra L Munger; Joseph Herbert; Alberto Ascherio
Journal:  Mult Scler       Date:  2011-08-03       Impact factor: 6.312

4.  Headache in multiple sclerosis: features and implications for disease management.

Authors:  David Tabby; Muhammad Hassan Majeed; Branden Youngman; Jessica Wilcox
Journal:  Int J MS Care       Date:  2013

Review 5.  Headache and Its Management in Patients With Multiple Sclerosis.

Authors:  Farhat Husain; Gabriel Pardo; Meheroz Rabadi
Journal:  Curr Treat Options Neurol       Date:  2018-03-24       Impact factor: 3.598

6.  Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.

Authors:  Elina Misicka; Corriene Sept; Farren B S Briggs
Journal:  J Neurol       Date:  2020-04-24       Impact factor: 4.849

7.  Spreading depression transiently disrupts myelin via interferon-gamma signaling.

Authors:  Aya D Pusic; Heidi M Mitchell; Phillip E Kunkler; Neal Klauer; Richard P Kraig
Journal:  Exp Neurol       Date:  2014-12-08       Impact factor: 5.330

Review 8.  Headache in multiple sclerosis and autoimmune disorders.

Authors:  L La Mantia; V Prone
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

9.  Smartphone based behavioral therapy for pain in multiple sclerosis (MS) patients: A feasibility acceptability randomized controlled study for the treatment of comorbid migraine and ms pain.

Authors:  Mia T Minen; Kathryn B Schaubhut; Kaitlyn Morio
Journal:  Mult Scler Relat Disord       Date:  2020-09-08       Impact factor: 4.339

10.  The use of focus groups to characterize symptoms in persons with multiple sclerosis.

Authors:  Pamela K Newland; Florian P Thomas; Marguerite Riley; Louise H Flick; Arleen Fearing
Journal:  J Neurosci Nurs       Date:  2012-12       Impact factor: 1.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.